Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
Dr. Cooney's research interests include early phase clinical trial development for pediatric central nervous system (CNS) tumors, developmental therapeutics, disparities, and diversity. She has presented her findings, including initial results from a Phase 1 trial in Panobinostat for children with diffuse intrinsic pontine glioma (DIPG) and a DIPG historical cohort, at international and national meetings. Dr. Cooney is actively involved in several pediatric brain tumor consortia, holds leadership committee positions in the Pediatric Neuro-Oncology Consortium (PNOC) and Response Assessment in Pediatric Neuro-Oncology (RAPNO), and is a rising leader in her field.
Dana-Farber Cancer Institute450 Brookline AvenueBoston, MA 02215Get Directions